Enhanced pathologic tumor response with two cycles of neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV-negative head and neck squamous cell carcinoma (HNSCC) Meeting Abstract
| Authors: | Uppaluri, R.; Chernock, R.; Mansour, M.; Jackson, R.; Rich, J.; Pipkorn, P.; Paniello, R. C.; Puram, S.; Zevallos, J. P.; Annino, D. J.; Goguen, L. A.; Morris, L.; Haddad, R. I.; Hanna, G. J.; Oppelt, P. J.; Dunn, L.; Ley, J. C.; Kallogjeri, D.; Egloff, A. M.; Adkins, D. |
| Abstract Title: | Enhanced pathologic tumor response with two cycles of neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV-negative head and neck squamous cell carcinoma (HNSCC) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120603201 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.6008 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 6008 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
